University of Oklahoma

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Oklahoma sits in the top decile of US sponsors by registered trial count (#100 of 15,742 sponsors by registered trial count).

358 total trials 80 currently recruiting 196 completed early-phase tilt top decile by trial count

University of Oklahoma: 358 sponsored US clinical trials, 80 recruiting.

University of Oklahoma sponsors 358 registered US clinical trials on ClinicalTrials.gov, 80 of them currently recruiting, and 196 completed. 26 of these trials are in Phase 3-4 (later-stage) and 88 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 6 trials.

Top-decile sponsor footprint

University of Oklahoma ranks in the top decile of sponsors by registered trial count (#100 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 44/100

196 of 240 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

358 total, page 6 of 8

TERMINATED Phase 3

Ranolazine for the Prevention of Atrial Fibrillation After Electrical Cardioversion

NCT01349491
COMPLETED NA

Tumor Markers in Lung Cancer: DCAMLK-1LK-1

NCT01578018
COMPLETED NA

Study of Efficacy and Tolerability of Various Bowel Preps in Diabetic Patients

NCT01533688
COMPLETED

Histologic Evaluation of Healing Following Tooth Extraction With Ridge Preservation Using NuOss XC and NuOss Particulate

NCT01391767
COMPLETED Phase 3

Safety and Efficacy Study of Fentanyl Buccal Tablet Use in the Emergency Department for Isolated Extremity Injury

NCT01270659
TERMINATED Phase 2

FOLFIRINOX in Patients With Inoperable Pancreatic Cancer

NCT01359007
COMPLETED NA

Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation

NCT01220687
COMPLETED Phase 1

Iloprost Effects on Gas Exchange and Pulmonary Mechanics

NCT01274481
COMPLETED

Vaginal Electrical Stimulation Versus Neuromodulation

NCT01525485
TERMINATED NA

Transcranial Direct Current Stimulation, Improve Functional Motor Recovery, Affected Arm

NCT01201629
TERMINATED Phase 1

Phase I Trial of 5-Azacitidine Plus Gemcitabine in Patients With Advanced Pancreatic Cancer

NCT01167816
TERMINATED NA

Efficacy of Statins In Prevention of CIN

NCT01071993
COMPLETED

Very Low Dose Caudal Morphine for Postoperative Pain Management

NCT00938821
COMPLETED

Influence of the Proton Pump Inhibitor Omeprazole on the Anti-Platelet of P2Y12 Antagonists in Subjects With Coronary and Peripheral Artery Disease

NCT01018940
TERMINATED Phase 2

Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera

NCT01038856
COMPLETED NA

Study of the Pharmacokinetics of Daptomycin in Children With Renal Disease

NCT01012089
COMPLETED

Coagulation Factors, Cytokines and Tissue Injury Markers in Sepsis

NCT01012115
COMPLETED

Comparison of a Novel 12-Lead Wireless Electrocardiogram (ECG) and a Standard Wired ECG

NCT00998842
COMPLETED Phase 3

Traditional Clomiphene Citrate Administration vs. Stair-step Approach

NCT01008319
TERMINATED NA

Reliability of Central Venous Pressure Measurements

NCT01116973
COMPLETED

Assisted Reproductive Technology (ART) Predictors Study

NCT00988611
COMPLETED NA

Effects of Yoga on Bone Metabolism in Premenopausal Women

NCT02163668
COMPLETED

Lifestyle Factors Study

NCT00989183
COMPLETED

Effects of Age on the Levator Ani Muscle of Nulliparous Women

NCT00964145
COMPLETED

Tumor Markers in Lung Cancer

NCT01274468
COMPLETED NA

The Effects of Lower Body Resistance Training on Balance and Fall Prevention in the Elderly

NCT01178970
COMPLETED NA

Exercise for Women With Peripheral Arterial Disease

NCT01241747
COMPLETED NA

Trial Comparing Outpatient Flexible to Rigid Cystoscopy in Females

NCT00945594
TERMINATED Phase 4

Cranial Electro Therapy Stimulation in Reducing Perioperative Anxiety

NCT00928772
COMPLETED

Urokinase Like Plasminogen Activator Levels in Patients Undergoing Bronchoscopy

NCT00929565
TERMINATED Phase 2

MemoryXL Effects on Mild Cognitive Impairment Patients

NCT00903695
TERMINATED

Incidence of Methicillin Resistant Staphylococcus Aureus (MRSA) Carriage Rates in Resident Physicians

NCT00929435
COMPLETED NA

Low Risk Acute Coronary Syndrome

NCT01703156
COMPLETED

Evaluation of Endovenous Sclerotherapy for Treatment of Varicose Veins

NCT00954980
COMPLETED NA

Study of the Effect of Differing Platelet Transfusion Times in Neonates

NCT00948792
TERMINATED NA

Use of Clearway™ Balloon vs. Mechanical Thrombectomy as Initial Treatment for Acute Limb Ischemia

NCT00869375
COMPLETED NA

Ultrasound Guided Arterial Line Placement in Long Axis Versus Short Axis in Pediatric Patients

NCT00859846
COMPLETED

Effect of Nasal CPAP on Cardiopulmonary Exercise Testing in Patients With Overlap Syndrome

NCT01033266
TERMINATED

Optical Coherence Tomography: An Adjunct to Flexible Bronchoscopy in the Diagnosis of Lung Cancer

NCT01039311
COMPLETED NA

Local Paclitaxel Delivery for SFA Disease

NCT00821028
TERMINATED Phase 2

Post-Operative Pain Scores and Analgesic Requirements After Elective Inguinal Herniorrhaphy

NCT00735124
COMPLETED NA

The Purpose of This Study is to Look at Pelvic Support Problems, Also Commonly Known as Pelvic Organ Prolapse

NCT00964197
COMPLETED Phase 2

Effects of Power Mobility on Young Children With Severe Motor Impairments

NCT01028833
COMPLETED NA

Reminding Patients of the Important of Colorectal Cancer Screening Results in Patient-Initiated Promoting Colorectal Cancer Screening Via Colonoscopy

NCT01526239
COMPLETED NA

A Comparison of the Effects of Intraoperative Administration of Metoprolol or Esmolol on General Anesthetic Requirement

NCT00756236
COMPLETED NA

Feasibility Study of Exercise in Patients With Leg Blood Clots

NCT00910364
COMPLETED NA

Liquid Preterm Formula Versus Powdered Human Milk Fortifier in VLBW Infants

NCT00760942
TERMINATED

Assessment of Suspected Intracranial Malignancy Using 3'-Deoxy-3'18 F-flourothymidine PET

NCT00775320
TERMINATED

Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma

NCT00775957
COMPLETED Early Phase 1

Closure Method Study Following Tonsillectomy in Children

NCT00730340
← Previous Page 6 of 8 Next →

Phase Distribution

PhaseTrial count
Phase 1 48
Phase 2 40
Phase 3 8
Phase 4 18

Therapeutic Areas

Prostate Cancer 6
Smoking Cessation 5
Health Behavior 4
Peripheral Artery Disease 4
Substance Use Disorders 4
Claudication 3
Cigarette Smoking 3
Tobacco Use 3
Atrial Fibrillation 3
Endometrial Cancer 3

What is open in the University of Oklahoma pipeline

80 recruiting of 358 indexed (22% open); 196 completed (55%).

Phase mix: 26 late (III/IV) vs 88 early (I/II) (early-phase heavy).

Top condition: Prostate Cancer (6 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Oklahoma: open-pipeline peers nationwide

Peers matched on 358 registered trials and 22% open enrollment, not the therapeutic-area sidebar.

University of Oklahoma sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300400 0%5%10%15%20%25% Total trials Recruiting share University of OklahomaNew York State Psychiatric InstituteRoswell Park Cancer InstituteUNC Lineberger Comprehensive Cancer CenterUniversity of ArizonaALX OncologyBiosense WebsterEnglewood Hospital and Medical CenterEnsysce Biosciences
University of Oklahoma sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Oklahoma sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 358 trials (± recruiting share)

Sponsors near 22% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of Oklahoma page

358 registered trials is a research-attention snapshot, not an endorsement of University of Oklahoma or any single study.

  • 80 of University of Oklahoma's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Prostate Cancer is the condition University of Oklahoma studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Oklahoma pipeline card: 358 registered trials from official public datasets.Report a data error.